Innovative Trauma Care is an Edmonton, Canada–based early-stage medical device company founded in 2010 that develops point-of-injury solutions to reduce preventable deaths from traumatic injury. Its flagship product is the ITClamp™ Hemorrhage Control System, designed to address massive hemorrhage. The company has U.S. headquarters in San Antonio, Texas, and is led by Dennis F. Filips (Vice-Chairman, President, and Chief Medical Officer). In its second financing the company raised $1.1M from members of the VA Angels. Proceeds will be used to expand sales and marketing efforts, fully commercialize the product, reduce cost of goods, and move the company toward profitability. Innovative Trauma Care develops point-of-injury medical devices to treat traumatic hemorrhage across trauma, first responder, and military medicine applications. Its lead product, the ITClamp Hemorrhage Control System, seals the skin to create a temporary pressurized pool that forms a stable clot and can control massive bleeding in as little as five seconds. The company closed a Series A financing of $3.64 million to prepare to commercialize the ITClamp. ITC received a license for sale from Health Canada in September 2012 and expects a CE Mark from the EU in late 2012 and U.S. FDA clearance in 2013. Incorporated in 2010, the company is based in Edmonton, Canada with a U.S. headquarters in San Antonio, Texas. ITC develops, manufactures, and plans to commercialize point-of-injury solutions addressing preventable deaths from traumatic injury.

Total raised

$5M

Funding rounds

2

Latest round

Equity

Latest activity

Nov 2013